throbber
Case 1:22-cv-01040-CFC Document 162 Filed 10/31/23 Page 1 of 4 PageID #: 4348
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`IN RE: OZEMPIC
`(SEMAGLUTIDE) PATENT
`LITIGATION
`
`MDL No. 22-MD-3038-CFC
`
`ANDA CASE
`
`NOVO NORDISK INC. and NOVO
`NORDISKA/S,
`
`Plaintiffs,
`
`V.
`
`C.A. No. 22-1040-CFC
`
`ANDA CASE
`
`MYLAN PHARMACEUTICALS
`INC.,
`
`Defendant.
`
`STIPULATION AND (PROPOSE~RDER
`REGARDING TRIAL OF THE MPI OZEMPIC LITIGATION
`
`WHEREAS, on March 18, 2022, Novo Nordisk Inc. and Novo Nordisk A/S
`
`("Plaintiffs") sued Mylan Pharmaceuticals Inc. ("MPI") in the United States District
`
`Court for the No1ihern District of West Virginia in a case captioned Novo Nordisk
`
`Inc. and Novo Nordisk AIS v. Mylan Pharmaceuticals Inc., No. 1:22-cv-23-JPB
`
`(N.D.W. Va.) ("MPI Ozempic Litigation"), D.I. l;
`
`WHEREAS, the MPI Ozempic Litigation is currently pending in the District
`
`of Delaware as Case No. 22-1040 (CFC) because, on August 5, 2022, the United
`
`States Judicial Panel on Multidistrict Litigation transfen-ed the MPI Ozempic
`
`Litigation to the United States District Court for the District of Delaware "for
`
`1
`
`Novo Nordisk Exhibit 2004
`Dr. Reddy's Laboratories v. Novo Nordisk A/S
`IPR2024-00009
`Page 00001
`
`

`

`Case 1:22-cv-01040-CFC Document 162 Filed 10/31/23 Page 2 of 4 PageID #: 4349
`
`coordinated or consolidated pretrial proceedings." In re Ozempic (Semaglutide)
`
`Patent Litigation, MDL No. 3038 (J.P.M.L.), D.I. 1;
`
`WHEREAS on March 21, 2023, Plaintiffs filed a First Amended Complaint
`
`against MPI in the MPI Ozempic Litigation (In re: Ozempic (Semaglutide) Patent
`
`Litigation, No. 22-md-3038 (D. Del.), D.I. 111);
`
`WHEREAS, for purposes of this case only, MPI will not dispute that the
`
`District of Delaware has personal jurisdiction and subject matter jurisdiction over
`
`the claims and counterclaims asserted in the MPI Ozempic Litigation under§§ 1331,
`
`1338(a), 2201, and/or 2202;
`
`WHEREAS, for purposes of this case only, MPI will not dispute that venue
`
`is proper in the District of Delaware;
`
`WHEREAS, based on the unique facts of this case, Plaintiffs and MPI agree
`
`all claims and counterclaims between them should remain in the District of Delaware
`
`for trial;
`
`WHEREAS, for purposes of this case only, MPI waives its ability to seek a
`
`remand of the MPI Ozempic Litigation to the Northern District of West Virginia
`
`following the conclusion of coordinated pretrial proceedings in In re Ozempic
`
`(Semaglutide) Patent Litigation, MDL No. 3038 (J.P.M.L.) and agrees that the MPI
`
`Ozempic Litigation shall remain in the District of Delaware for trial as part of In re
`
`Ozempic (Semaglutide) Patent Litigation, MDL No. 22-MD-3038 (CFC).
`
`2
`
`Novo Nordisk Exhibit 2004
`Dr. Reddy's Laboratories v. Novo Nordisk A/S
`IPR2024-00009
`Page 00002
`
`

`

`Case 1:22-cv-01040-CFC Document 162 Filed 10/31/23 Page 3 of 4 PageID #: 4350
`
`IT IS HEREBY STIPULATED, subject to the approval of the Court, that
`
`Plaintiffs and MPI will remain in the District of Delaware for trial of all claims and
`
`counterclaims raised in In re Ozempic (Semaglutide) Patent Litigation, MDL No.
`
`3038 (J.P.M.L.) and in the MPI Ozempic Litigation, which was originally filed as
`
`Novo Nordisk Inc. and Novo Nordisk AIS v. Mylan Pharmaceuticals Inc., No. 1 :22-
`
`cv-23-JPB (N.D.W. Va.), and is presently pending as Case No. 22-1040 (CFC) (D.
`
`Del.). All such claims and counterclaims shall be tried as part of the trial presently
`
`scheduled to begin in Delaware on September 30, 2024 in In re Ozempic
`
`(Semaglutide) Patent Litigation, MDL No. 22-MD-3038 (CFC), which includes the
`
`consolidated cases pending under Lead Case No. 22-294 (CFC) and the MPI
`
`Ozempic Litigation.
`
`MORRIS,NICHOLS,ARsHf &TuNNELLLLP
`
`STAMOULIS & WEINBLA TT LLC
`
`/s/ <Travis J. :M.urray
`
`/s/ Stamatios Stamou{is
`
`Stamatios Stamoulis ( #4606)
`Richard C. Weinblatt (#5080)
`800 North West Street, 3rd Floor
`Wilmington, DE 19801
`(302) 999-1540
`stamoulis@swdelaw.com
`weinblatt@swdelaw.com
`
`Attorneys for Defendant
`Mylan Pharmaceuticals Inc.
`
`Jack B. Blumenfeld (#1014)
`Brian P. Egan (#6227)
`Travis J. Murray (#6882)
`1201 North Market Street
`P.O. Box 1347
`Wilmington, DE 19899
`(302) 658-9200
`jblumenfeld@morrisnichols.com
`began@morrisnichols.com
`tmurray@morrisnichols.com
`
`Attorneys for Plaintiffs Novo Nordisk
`Inc. and Novo Nordisk AIS
`
`3
`
`Novo Nordisk Exhibit 2004
`Dr. Reddy's Laboratories v. Novo Nordisk A/S
`IPR2024-00009
`Page 00003
`
`

`

`Case 1:22-cv-01040-CFC Document 162 Filed 10/31/23 Page 4 of 4 PageID #: 4351
`
`SO ORDERED this Ji✓r day of Q c;f.Lv
`
`, 2023.
`
`The Honorable Cohn F. Connolly
`Chief, United States District Judge
`
`4
`
`Novo Nordisk Exhibit 2004
`Dr. Reddy's Laboratories v. Novo Nordisk A/S
`IPR2024-00009
`Page 00004
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket